Categories
  Encyclosphere.org ENCYCLOREADER
  supported by EncyclosphereKSF

DALDA

From HandWiki - Reading time: 3 min


DALDA (H-Tyr-D-Arg-Phe-Lys-NH2) is a synthetic peptide derivative which acts as a potent and highly selective agonist of the mu opioid receptor. It was originally derived as a more metabolically stable analogue of dermorphin, a naturally occurring opioid peptide secreted by some species of South American frogs.[1][2][3] DALDA is unable to cross the blood-brain barrier, making it highly peripherally selective, but it has been researched for the treatment of colitis and neuropathic pain, where peripheral opioid agonism is able to produce analgesic effects in the absence of central opioid receptor activation.[4][5][6][7][8][9][10][11][12] Some derivatives of DALDA such as [Dmt1]DALDA (where the tyrosine residue has been substituted with 2,6-dimethyl groups) or more complexly modified derivatives such as KGOP01, do however cross the blood-brain barrier and produce typical opioid effects.[13][14][15][16][17][18][19][20]

[Dmt1]DALDA, CAS# 255861-98-4 PMID 9809562

References

  1. "Dermorphin analogues carrying an increased positive net charge in their "message" domain display extremely high mu opioid receptor selectivity". Journal of Medicinal Chemistry 32 (3): 698–703. March 1989. doi:10.1021/jm00123a035. PMID 2537427. 
  2. "In vivo pharmacokinetics of selective mu-opioid peptide agonists". The Journal of Pharmacology and Experimental Therapeutics 298 (1): 57–61. July 2001. doi:10.1016/S0022-3565(24)29351-4. PMID 11408525. 
  3. "Conformation-activity relationships of cyclo-constrained micro/delta opioid agonists derived from the N-terminal tetrapeptide segment of dermorphin/deltorphin". Journal of Peptide Science 14 (8): 898–902. August 2008. doi:10.1002/psc.1022. PMID 18338322. 
  4. "Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation". The Journal of Clinical Investigation 111 (9): 1329–1338. May 2003. doi:10.1172/JCI16750. PMID 12727924. 
  5. "Activation of Peripheral μ-opioid Receptors by Dermorphin [D-Arg2, Lys4 (1-4) Amide Leads to Modality-preferred Inhibition of Neuropathic Pain"]. Anesthesiology 124 (3): 706–720. March 2016. doi:10.1097/ALN.0000000000000993. PMID 26756519. 
  6. "Role of peripheral sensory neuron mu-opioid receptors in nociceptive, inflammatory, and neuropathic pain". Regional Anesthesia and Pain Medicine 45 (11): 907–916. November 2020. doi:10.1136/rapm-2020-101779. PMID 32928995. 
  7. "OCP002, a Mixed Agonist of Opioid and Cannabinoid Receptors, Produces Potent Antinociception With Minimized Side Effects". Anesthesia and Analgesia 136 (2): 373–386. February 2023. doi:10.1213/ANE.0000000000006266. PMID 36638515. 
  8. "Peripheral mu-opioid receptor activation by dermorphin [D-Arg2, Lys4 (1-4) amide alleviates behavioral and neurobiological aberrations in rat model of chemotherapy-induced neuropathic pain"]. Neurotherapeutics 21 (1). January 2024. doi:10.1016/j.neurot.2023.10.012. PMID 38241153. 
  9. "Dermorphin [D-Arg2, Lys4] (1-4) Amide Alleviates Frostbite-Induced Pain by Regulating TRP Channel-Mediated Microglial Activation and Neuroinflammation". Molecular Neurobiology 61 (8): 6089–6100. August 2024. doi:10.1007/s12035-024-03949-4. PMID 38277118. 
  10. "Peripherally restricted cannabinoid and mu-opioid receptor agonists synergistically attenuate neuropathic mechanical hypersensitivity in mice". Pain 165 (11): 2563–2577. November 2024. doi:10.1097/j.pain.0000000000003278. PMID 38815196. 
  11. "Characterizing a new rat model of chronic pain after spine surgery". Bone Research 13 (1). March 2025. doi:10.1038/s41413-025-00408-1. PMID 40074742. 
  12. "Dermorphin [D-Arg2, Lys4] (1-4) Amide Attenuates Burn Pain by Inhibiting TRPV1/NR2B Mediated Neuroinflammatory Signalling". Molecular Neurobiology 62 (10): 12668–12687. October 2025. doi:10.1007/s12035-025-05068-0. PMID 40442534. 
  13. "Synthesis and in vitro opioid activity profiles of DALDA analogues". European Journal of Medicinal Chemistry 35 (10): 895–901. October 2000. doi:10.1016/s0223-5234(00)01171-5. PMID 11121615. 
  14. "Antinociceptive and respiratory effects of intrathecal H-Tyr-D-Arg-Phe-Lys-NH2 (DALDA) and [Dmt1] DALDA". The Journal of Pharmacology and Experimental Therapeutics 297 (1): 364–371. April 2001. doi:10.1016/S0022-3565(24)29547-1. PMID 11259564. 
  15. "Pharmacological characterization of the dermorphin analog [Dmt(1)]DALDA, a highly potent and selective mu-opioid peptide". European Journal of Pharmacology 419 (1): 15–23. May 2001. doi:10.1016/s0014-2999(01)00946-3. PMID 11348625. 
  16. "Opioid peptide-derived analgesics". The AAPS Journal 7 (3): E560–E565. October 2005. doi:10.1208/aapsj070356. PMID 16353933. 
  17. "Bi- or multifunctional opioid peptide drugs". Life Sciences 86 (15–16): 598–603. April 2010. doi:10.1016/j.lfs.2009.02.025. PMID 19285088. 
  18. "Superior analgesic effect of H-Dmt-D-Arg-Phe-Lys-NH2 ([Dmt1DALDA), a multifunctional opioid peptide, compared to morphine in a rat model of neuropathic pain"]. Chemical Biology & Drug Design 80 (5): 771–774. November 2012. doi:10.1111/cbdd.12003. PMID 22834682. 
  19. "Mechanistic Understanding of Peptide Analogues, DALDA, [Dmt1DALDA, and KGOP01, Binding to the mu Opioid Receptor"]. Molecules 25 (9): 2087. April 2020. doi:10.3390/molecules25092087. PMID 32365707. 
  20. "Identification of the dermorphin tetrapeptide [Dmt1 ]-DALDA in a seized unlabelled vial and its first detection in horse urine: A case report". Drug Testing and Analysis 16 (3): 268–276. March 2024. doi:10.1002/dta.3536. PMID 37408356. 




Licensed under CC BY-SA 3.0 | Source: https://handwiki.org/wiki/Chemistry:DALDA
1 views |
↧ Download this article as ZWI file
Encyclosphere.org EncycloReader is supported by the EncyclosphereKSF